The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995.

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMID 9874470)

Published in Cancer on December 15, 1998

Authors

J H Donohue1, A K Stewart, H R Menck

Author Affiliations

1: Division of General and Gastroenterologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Articles citing this

Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg (2007) 3.38

NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25

Incidental carcinoma gall bladder during laparoscopic cholecystectomy for symptomatic gall stone disease. Surg Endosc (2008) 1.14

Appraisal of surgical treatment for pT2 gallbladder carcinomas. World J Surg (2004) 1.04

Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surg Endosc (2010) 1.03

Gallbladder cancer in the twentieth century: single institution's experience. World J Surg (2003) 1.00

Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol (2009) 0.97

Diagnosis of incidental gallbladder cancer after laparoscopic cholecystectomy: our experience. BMC Surg (2013) 0.94

A conceptual proposal for staging ductal cholangiocarcinoma. Curr Opin Gastroenterol (2009) 0.93

The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma. HPB (Oxford) (2008) 0.91

Laparoscopic cholecystectomy for early gallbladder carcinoma: long-term outcome in comparison with conventional open cholecystectomy. Surg Endosc (2006) 0.91

Prognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma. Nucl Med Mol Imaging (2012) 0.90

Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature. HPB (Oxford) (2008) 0.90

Are histological alterations observed in the gallbladder precancerous lesions? Clinics (Sao Paulo) (2010) 0.87

Postoperative chemoradiotherapy for gallbladder cancer. Strahlenther Onkol (2012) 0.83

TNF-α promotes gallbladder cancer cell growth and invasion through autocrine mechanisms. Int J Mol Med (2014) 0.81

Conformal radiotherapy for squamous cell carcinoma of gallbladder: a case report. Case Rep Med (2010) 0.79

Laparoscopic radical cholecystectomy for suspected early gall bladder carcinoma: thinking beyond convention. Surg Endosc (2015) 0.79

Simultaneous detection of synchronous colonic and biliary carcinoma by abdominal ultrasonography in two patients with ulcerative colitis. Dig Dis Sci (2005) 0.78

Gallbladder selection for histopathological analysis based on a simple method: a prospective comparative study. Ann R Coll Surg Engl (2012) 0.78

Role of radical surgery in patients with stage IV gallbladder cancer. HPB (Oxford) (2012) 0.77

Management and diagnosis of gallbladder polyps: a systematic review. Langenbecks Arch Surg (2015) 0.76

Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. Ann Surg Oncol (2013) 0.76

Tea consumption and risk of gallbladder cancer: A meta-analysis of epidemiological studies. Mol Clin Oncol (2015) 0.76

Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins. Mol Med Rep (2016) 0.76

Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry. Cancers (Basel) (2010) 0.75

Pachymic acid inhibits tumorigenesis in gallbladder carcinoma cells. Int J Clin Exp Med (2015) 0.75

Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: setting an evidence-based benchmark for the best-quality cancer care. Gastroenterol Res Pract (2015) 0.75

Multidisciplinary collaboration in gallbladder carcinoma treatment: A case report and literature review. Oncol Lett (2016) 0.75

Incidental gallbladder cancer after routine cholecystectomy: when should we suspect it preoperatively and what are predictors of patient survival? Ann Surg Treat Res (2016) 0.75

Analysis of trefoil factor family protein 1 (TFF1, pS2) expression in chronic cholecystitis and gallbladder carcinoma. Virchows Arch (2005) 0.75

Adjuvant therapy in biliary tract and gall bladder carcinomas: a review. J Gastrointest Oncol (2017) 0.75

Articles by these authors

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]. Cancer (1998) 8.03

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1998) 6.22

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg (1999) 5.58

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia (2009) 4.91

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer (2000) 3.57

Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1999) 3.04

Clinically relevant end points and new drug approvals for myeloma. Leukemia (2007) 2.91

The National Cancer Data Base report on pancreatic cancer. Cancer (1995) 2.77

Genetic aberrations and survival in plasma cell leukemia. Leukemia (2008) 2.69

Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer (1999) 2.64

Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia (2009) 2.50

Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg (2000) 2.48

Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer (1979) 2.39

Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys (2001) 2.33

Factors influencing the use of breast reconstruction postmastectomy: a National Cancer Database study. J Am Coll Surg (2001) 2.21

Occupational differences in rates of lung cancer. J Occup Med (1976) 2.19

Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer (2000) 2.11

Superior survival of young women with malignant melanoma. Am J Surg (1998) 2.09

Factors associated with survival in patients with meningioma. J Neurosurg (1998) 2.06

Brain tumor survival: results from the National Cancer Data Base. J Neurooncol (1998) 1.98

Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial. Leukemia (2009) 1.97

The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg (1998) 1.96

The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer (1999) 1.93

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study. Leukemia (2013) 1.84

National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcome. Cancer (2001) 1.77

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM). Leukemia (2010) 1.77

The National Cancer Data Base report on lung cancer. Cancer (1996) 1.72

National Cancer Data Base report on esophageal carcinoma. Cancer (1996) 1.70

The National Cancer Data Base report on cancer of the vagina. Cancer (1998) 1.69

National cancer database report on chondrosarcoma of the head and neck. Head Neck (2000) 1.69

Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg (1996) 1.62

The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer (1999) 1.58

Clinical highlights from the National Cancer Data Base: 1994. CA Cancer J Clin (1994) 1.58

The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer (1998) 1.54

The National Cancer Data Base. Report on colon cancer. Cancer (1996) 1.53

The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer (1996) 1.50

The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia. Cancer (1999) 1.49

The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer (1997) 1.47

Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest (1992) 1.46

National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck (1999) 1.45

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer (1998) 1.43

The undescended testis: management after puberty. J Urol (1975) 1.43

The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer (1997) 1.38

National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. Ann Surg (1996) 1.35

The National Cancer Data Base report on non-Hodgkin's lymphoma. Cancer (1997) 1.35

Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg (1995) 1.30

An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery (1999) 1.29

Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma. Leukemia (2008) 1.24

The National Cancer Data Base report on gastric carcinoma. Cancer (1997) 1.23

The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996. Cancer (2000) 1.23

Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis. Blood (2000) 1.21

Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276. Leukemia (2013) 1.21

The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer (1997) 1.21

Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood (2000) 1.21

Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood (1999) 1.20

A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg (1998) 1.17

Regional differences in surgical management of breast cancer. CA Cancer J Clin (1992) 1.17

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells. Blood (2001) 1.17

The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1996) 1.13

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1998) 1.12

Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Causes Control (1994) 1.11

HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells. Oncogene (2001) 1.11

The National Cancer Data Base report on soft tissue sarcoma. Cancer (1996) 1.10

Industrial air pollution: possible effect on lung cancer. Science (1974) 1.09

The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer (1998) 1.08

The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-95. Cancer (1998) 1.06

Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. Blood (1999) 1.06

A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer (1997) 1.05

National Cancer Data Base survey of breast cancer management for patients from low income zip codes. Cancer (2000) 1.05

Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg (1997) 1.05

The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer (1996) 1.04

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04

The National Cancer Data Base report on ovarian cancer treatment in United States hospitals. Cancer (1996) 1.04

Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells. Int J Oncol (1999) 1.03

Peptide mimics as substrates for the intestinal peptide transporter. J Biol Chem (1998) 1.02

Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation. Bone Marrow Transplant (2005) 1.01

Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Bone Marrow Transplant (2004) 0.99

Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer (2000) 0.99

Lung cancer risk among beauticians and other female workers: brief communication. J Natl Cancer Inst (1977) 0.98

Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol (1994) 0.98

The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996. Cancer (1999) 0.97

The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM staging. Cancer (1997) 0.97

A national quality improvement effort: cancer registry data. J Surg Oncol (1995) 0.96

Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant (2001) 0.96

The National Cancer Data Base report on carcinoma of the anus. Cancer (1997) 0.96

The National Cancer Data Base. A mechanism for assessment of patient care. Cancer (1994) 0.96

Testicular plasmacytoma following chemical orchiectomy: potential role of hypogonadism in myeloma proliferation. Leuk Lymphoma (1998) 0.95

Clinical highlights from the National Cancer Data Base, 1999. CA Cancer J Clin (1999) 0.95

The National Cancer Data Base: report on kidney cancers. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1997) 0.95

Disease severity and radioactive iodine use for thyroid cancer. J Clin Endocrinol Metab (2013) 0.94

Ovarian function after autologous bone marrow transplantation. J Clin Oncol (1998) 0.94

Lessons from next-generation sequencing analysis in hematological malignancies. Blood Cancer J (2013) 0.94

The National Cancer Data Base report on patterns of hospital reporting. Cancer (1996) 0.94